Sale!

GLRA1 Gene Hyperekplexia Genetic Test

Original price was: $700.Current price is: $500.

-29%

The GLRA1 Gene Hyperekplexia NGS Genetic DNA Test is a cutting-edge genetic analysis designed to identify mutations in the GLRA1 gene responsible for hereditary hyperekplexia, a rare neurological disorder characterized by excessive startle responses. This comprehensive test utilizes next-generation sequencing technology to provide accurate detection of genetic variants associated with this condition. The test is particularly valuable for individuals experiencing unexplained exaggerated startle reflexes, muscle stiffness, and other neurological symptoms. By identifying the specific genetic cause, patients and healthcare providers can develop targeted treatment strategies and understand inheritance patterns. The test is available for $500 USD (discounted from $700 USD) and provides results within 3-4 weeks using blood, extracted DNA, or blood spot samples.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

GLRA1 Gene Hyperekplexia NGS Genetic DNA Test

Comprehensive Genetic Analysis for Hereditary Startle Disorders

The GLRA1 Gene Hyperekplexia NGS Genetic DNA Test represents a significant advancement in neurological genetic diagnostics, offering precise identification of mutations in the GLRA1 gene associated with hereditary hyperekplexia. This rare neurological condition, often referred to as “startle disease,” affects the glycine receptor system in the central nervous system, leading to exaggerated startle responses and muscle stiffness. Our state-of-the-art testing utilizes next-generation sequencing technology to provide comprehensive analysis with exceptional accuracy and reliability.

What Does This Test Measure and Detect?

This specialized genetic test specifically targets the GLRA1 gene, which encodes the alpha-1 subunit of the glycine receptor. The test detects:

  • Point mutations and single nucleotide variants in the GLRA1 gene
  • Small insertions and deletions affecting gene function
  • Missense, nonsense, and frameshift mutations
  • Genetic variants associated with autosomal dominant and recessive inheritance patterns
  • Pathogenic mutations linked to hyperekplexia severity and clinical presentation

Who Should Consider This Genetic Test?

This test is recommended for individuals experiencing the following symptoms or clinical scenarios:

  • Unexplained exaggerated startle responses to unexpected stimuli
  • Generalized muscle stiffness, particularly in infancy
  • Family history of hyperekplexia or similar neurological conditions
  • Infants with hypertonia and exaggerated startle reflexes
  • Individuals with suspected hereditary neurological disorders
  • Patients with treatment-resistant muscle stiffness or spasms
  • Those seeking genetic counseling for family planning purposes

Key Benefits of GLRA1 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages for patients and healthcare providers:

  • Accurate Diagnosis: Provides definitive genetic confirmation of hyperekplexia
  • Personalized Treatment: Enables targeted therapeutic approaches based on specific mutations
  • Family Planning: Offers valuable information for genetic counseling and inheritance risk assessment
  • Early Intervention: Facilitates timely management strategies for affected infants and children
  • Differential Diagnosis: Helps distinguish hyperekplexia from other neurological conditions
  • Prognostic Information: Provides insights into disease progression and potential complications

Understanding Your Test Results

Our comprehensive genetic report provides detailed interpretation of your results with clinical context:

  • Positive Result: Indicates the presence of a pathogenic mutation in the GLRA1 gene, confirming hereditary hyperekplexia diagnosis
  • Negative Result: Suggests that GLRA1 mutations are not the cause of symptoms, though other genetic factors may be considered
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications, requiring further evaluation
  • Carrier Status: Determines if individuals carry mutations that could be passed to offspring

All results are accompanied by detailed clinical interpretation and recommendations for next steps. Genetic counseling is strongly recommended to fully understand the implications of your test results.

Test Pricing and Availability

Test Name Discount Price Regular Price
GLRA1 Gene Hyperekplexia NGS Genetic DNA Test $500 USD $700 USD

Nationwide Testing Availability

GGC DNA provides comprehensive genetic testing services across the United States with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.

Pre-Test Requirements and Sample Collection

Before testing, we recommend:

  • Comprehensive clinical history documentation
  • Genetic counseling session to create detailed family pedigree
  • Discussion of testing implications and potential outcomes

Sample Types Accepted: Blood, Extracted DNA, or One Drop Blood on FTA Card

Turnaround Time: 3 to 4 Weeks

Take Control of Your Neurological Health Today

Don’t let unexplained neurological symptoms affect your quality of life. Our GLRA1 Gene Hyperekplexia NGS Genetic DNA Test provides the clarity and answers you need for proper diagnosis and management. With our discounted pricing and nationwide availability, accessing advanced genetic testing has never been more convenient.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic testing appointment or to speak with our genetic counseling team. Take the first step toward understanding your neurological health with confidence and precision.